CINRX PHARMA
CinRx Pharma was launched in September of 2015 to transform the development of innovative therapies addressing substantial unmet medical needs. With leading CRO Medpace as a strategic partner, CinRx leverages its cost-efficient structure while having access to global clinical development expertise and networks of advisors, critical understanding of the evolving regulatory environment, and industry-leading track records of execution across all stages of R&D. CinRx’s therapeutic pipeline focuse... s on innovative and disruptive new molecular entities (NMEs). CinRx pursues an expedited path of development to achieve significant value inflection points for each of its programs. Once a compound has demonstrated clinical and commercial value, CinRx will determine the optimal strategy to bring the product to patients.
CINRX PHARMA
Industry:
Biotechnology Health Care Pharmaceutical
Founded:
2015-09-01
Status:
Active
Contact:
844-531-1834
Email Addresses:
[email protected]
Total Funding:
38.41 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Font API Apple Mobile Web Clips Icon WordPress Font Awesome Euro WordPress 6.0 WPBakery ThemePunch
Similar Organizations
Arbutus Biopharma
Arbutus Biopharma Corporation is a publicly-traded biopharmaceutical company.
Frontier Biotechnologies
Frontier Biotechnologies is a commercial-stage bio-pharmaceutical company.
kancera
Kancera carries out pharmaceutical development,
OncoQuest
OncoQuest is a Edmonton-based biopharmaceutical company.
ORIC Pharmaceuticals
ORIC Pharmaceuticals operates as a biopharmaceutical company.
Current Employees Featured
Founder
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2021-10-12 | CinCor Pharma | CinRx Pharma investment in Series B - CinCor Pharma | 143 M USD |
More informations about "CinRx Pharma"
About - CINRX Pharma
Our Model CinRx Pharma is a biotech company accelerating promising, high-impact medicines through clinical development with a unique hub and spoke model. This approach enables us to …See details»
CinRx Pharma - Crunchbase Company Profile & Funding
CinRx Pharma raised $73 million to continue its 'Hub and Spoke' model of startup formation. Additionally, its portfolio company CinDome raised $40 million toward a Series B round. CinFina Pharma, another portfolio company, announced FDA …See details»
CinDome | A CinRx Portfolio Company
Apr 29, 2024 CinDome Pharma is a CinRx portfolio company. CinRx deploys a hub-and-spoke approach in advancing its portfolio of multiple biotechnology companies, each rapidly …See details»
CinRx Pharma - LinkedIn
CinRx Pharma is a biotech company advancing a diverse portfolio of high-impact medicines through clinical development with a unique hub-and-spoke business model.See details»
CinRx Pharma Company Profile 2025: Valuation, …
CinRx Pharma’s most recent deal was a Early Stage VC with CinDome Pharma for . The deal was made on 16-May-2024. The deal was made on 16-May-2024. Company NameSee details»
CinRx Pharma, LLC Company Profile - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for CinRx Pharma, LLC of Cincinnati, OH. Get the latest business insights from Dun & Bradstreet.See details»
CinFina | A CinRx Portfolio Company
Nov 5, 2024 CinFina Pharma is a CinRx portfolio company. CinRx deploys a hub-and-spoke approach in advancing its portfolio of multiple biotechnology companies, each rapidly …See details»
CinRx Pharma Announces Additional $73 Million Financing
May 30, 2024 CinRx Pharma is a biotech company advancing a diverse portfolio of high-impact medicines through clinical development with a unique hub-and-spoke business model. CinRx’s …See details»
Organization | CinRx Pharma
Organization Overview. First Clinical Trial. 2020 NCT04208698. First Marketed Drug. None First NDA Approval. None ... CinPhloro Pharma, LLC | CinRx | CinRx Pharma Active Ingredients. …See details»
CinRx Pharma Announces Additional $73 Million Financing
CINCINNATI, May 30, 2024--CinRx Pharma, a hub-and-spoke biotech accelerating high-impact medicines, today announced the closing of a $73 million financing, bringing the total funds …See details»
CinRx Pharma LLC - Drug pipelines, Patents, Clinical trials - Synapse
About CinRx Pharma: CinRx Pharma is a biotech company advancing a diverse portfolio of high-impact medicines through clinical development with a unique hub-and-spoke business model. …See details»
CinRx Pharma - CEO and Investor Conference 2025 - bcic.bio.org
The BIO CEO & Investor Conference offers a collaborative forum where executives, investors and industry stakeholders can come together to learn and exchange ideas about innovation in the …See details»
CinRx Company Profile - Office Locations, Competitors, Revenue
CinRx has 5 employees at their 1 location and $36 m in total funding,. See insights on CinRx including office locations, competitors, revenue, financials, executives, subsidiaries and more …See details»
CinFina Pharma Announces Initiation of Phase 1 Multiple
CINCINNATI, July 30, 2024 – CinFina Pharma, a CinRx portfolio company dedicated to advancing a portfolio of high-impact treatment options for obesity and metabolic diseases, today …See details»
CinRx Pharma - Products, Competitors, Financials, Employees ...
CinRx Pharma operates as a biotech company focused on the development of high-impact medicines across various therapeutic areas. The company invests in and guides drug …See details»
CinRx Pharma - Contacts, Employees, Board Members
CinRx Pharma has 5 current employee profiles, including President & CEO Jonathan Isaacsohn. Contacts. Edit Contacts Section. Job Department. Protected Content. Chief Medical Officer. …See details»
CinRx Pharma Careers, Perks + Culture - Built In
CinRx Pharma is a mosaic of biotechnology companies supported by a dedicated funding mechanism designed to improve drug development success by accelerating promising new …See details»
Portfolio - CINRX Pharma
Cinrx in the news CinFina Pharma Presents Positive Phase 1 Study Results in Poster Session for CIN-109 and in Late-Breaking Poster for CIN-110, Demonstrating the Potential of Next …See details»
CIN-109 - Drug Targets, Indications, Patents - Synapse
About CinRx Pharma: CinRx Pharma is a biotech company advancing a diverse portfolio of high-impact medicines through clinical development with a unique hub-and-spoke business model. …See details»